Status:
COMPLETED
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
Lead Sponsor:
HealthPartners Institute
Conditions:
Sleep
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.
Eligibility Criteria
Inclusion
- Age \>=18 years
- In-center diagnostic or split night sleep study (PSG)
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
September 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2020
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04102345
Start Date
September 4 2019
End Date
November 10 2020
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regions Hospital Sleep Center
Maplewood, Minnesota, United States, 55109